Discovery of new antitubercular oxazolyl thiosemicarbazones

Journal of Medicinal Chemistry

Volumn 49, Issue 12, 2006, Pages 3448-3450

  Sriram, Dharmarajan ^a   Yogeeswari, Perumal ^a   Thirumurugan, Rathinasababathy ^a   Pavana, Roheet Kumar ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

(4 BROMOPHENYL)(PHENYL)METHANONE N (5 CYCLOBUTYL 1,3 OXAZOL 2 YL)THIOSEMICARBAZONE; THIOSEMICARBAZONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPLEEN; STRUCTURE ACTIVITY RELATION; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOSEMICARBAZONES;

EID: 33745139827     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060339h     Document Type: Article

References (12)

1. Corbett, E. L.; Watt, C. J.; Walker, N.; Maher, D.; Williams, B. G.; Raviglione, M. C.; Dye, C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 2003, 1639, 1009-1021.
2. De Jong, B. C.; Israelski, D. M.; Corbett, E. L.; Small, P. M. Clinical management of tuberculosis in the context of HIV infection. Annu. Rev. Med. 2004, 55, 283-301.
3. Alland, D.; Kalkut, G. E.; Moss, A. R. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 1994, 330, 1710.
4. Whalen, C.; Horsburgh, C. R.; Horn, D. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 1995, 151, 129.
5. Sriram, D.; Yogeeswari, P.; Thirumurugan, R. Antituberculous activity of some aryl semicarbazone derivatives. Bioorg. Med. Chem. Lett. 2004, 14, 3923-3924.
6. George, C.; Harrison, D.; Harvey, D. β-Ethoxypropionitrile. Org. Synth. 1955, 3, 372 (Collective).
7. Yoon, N. M.; Gyoung, Y. S. Reaction of diisobutylaluminium hydride with selected organic compounds containing representative functional groups. J. Org. Chem. 1985, 50, 2443-2450.
8. Crank, G.; Foulis, M. J. Derivatives of 2-aminooxazoles showing anti-inflammatory activity. J. Med. Chem. 1971, 14, 1075-1077.
9. Bah T. R.; Anand, B.; Yogeeswari, P.: Sriram, D. Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives Bioorg. Med. Chem. Lett. 2005, 15, 4451-4455.
10. Antimycobacterial Susceptibility Testing for Mycobacterium Tuberculosis. Proposed Standard M24-T; National Committee for Clinical Laboratory Standards: Villanova, PA, 1995.
11. Gundersen, L. L.; Nissen-Meyer, J.; Spilsberg, B. Synthesis and antimycobacterial activity of 6-arylpurines: The requirements for the N-9 substituent in active antimycobacterial purines. J. Med. Chem. 2002, 45, 1383-1386.
12. Sriram, D.; Yogeeswari, P.; Basha, S. J.; Radha, D. R.; Nagaraja, V. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg. Med. Chem. 2005, 13, 5774-5778.